Skip to main content
. 2023 Nov 20;271(2):699–710. doi: 10.1007/s00415-023-12084-4

Fig. 3.

Fig. 3

Relapses Cumulative Hazard curves, right-censored at 40 weeks after pre-lock infusion: the two populations were compared according to dichotomized interval dosing ≤ 30 weeks versus > 30 weeks, focusing the analysis within the 40th week after pre-lock infusion